Abstract:Background The microRNA miR-221-3p has previously been found to be an underlying biomarker of pancreatic cancer. However, the mechanisms of miR-221-3p underlying its role in pancreatic cancer pathogenesis, proliferation capability, invasion ability, drug resistance and apoptosis and the clinicopathological value of miR-221-3p have not been thoroughly studied. Methods Based on microarray and miRNA-sequencing data extracted from Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), relevant literature, and real-time quantitative PCR (RT-qPCR), we explored clinicopathological features and the expression of miR-221-3p to determine its clinical effect in pancreatic cancer. Proliferation, migration, invasion, apoptosis and in vitro cytotoxicity tests were selected to examine the roles of mir-221-3p. In addition, several miR-221-3p functional analyses were conducted, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein-protein interaction (PPI) network analyses, to examine gene interactions with miR-221-3p. Results The findings of integrated multi-analysis revealed higher miR-221-3p expression in pancreatic cancer tissues and blood than that in para-carcinoma samples (SMD of miR-221-3p: 1.52; 95% CI 0.96, 2.08). MiR-221-3p is related to survival both in pancreatic cancer and pancreatic ductal adenocarcinoma patients. Cell experiments demonstrated that miR-221-3p promotes pancreatic cancer cell proliferation capability, migration ability, invasion ability, and drug resistance but inhibits apoptosis. Further pancreatic cancer bioinformatics analyses projected 30 genes as the underlying targets of miR-221-3p. The genes were significantly distributed in diverse critical pathways, including microRNAs in cancer, viral carcinogenesis, and the PI3K-Akt signalling pathway. Additionally, PPI indicated four hub genes with threshold values of 5: KIT, CDKN1B, RUNX2, and BCL2L11. Moreover, cell studies showed that miR-221-3p can inhibit these four hub genes expression in pancreatic cancer. Conclusions Our research revealed that pancreatic cancer expresses a high-level of miR-221-3p, indicating a potential miR-221-3p role as a prognosis predictor in pancreatic cancer. Moreover, miR-221-3p promotes proliferation capacity, migration ability, invasion ability, and drug resistance but inhibits apoptosis in pancreatic cancer. The function of miR-221-3p in the development of pancreatic cancer may be mediated by the inhibition of hub genes expression. All these results might provide an opportunity to extend the understanding of pancreatic cancer pathogenesis.

Downregulation of Mir-221 Enhances the Sensitivity of Human Oral Squamous Cell Carcinoma Cells to Adriamycin Through Upregulation of TIMP3 Expression.

MicroRNA-215 is Upregulated by Treatment with Adriamycin and Leads to the Chemoresistance of Hepatocellular Carcinoma Cells and Tissues.

Downregulation of Microrna 99a in Oral Squamous Cell Carcinomas Contributes to the Growth and Survival of Oral Cancer Cells.

Effects of Abnormal Expression of Mir-221 on Proliferation and Apoptosis of Gastric Cancer Cell Lines

[MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid Leukemia]

Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.

MicroRNAs Contribute to the Chemoresistance of Cisplatin in Tongue Squamous Cell Carcinoma Lines.

Mir-222 Modulates Multidrug Resistance in Human Colorectal Carcinoma by Down-Regulating Adam-17

Effect of Silencing Survivin Gene on Sensitivity of Myeloma Cells to Adriamycin

The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin

Mirna-221 Acts As an Oncogenic Role by Directly Targeting TIMP2 in Non-Small-cell Lung Carcinoma.

The Role of Mir-221 in Regulating Gastric Cancer Radiation Sensitivity

Downregulation of Mir-221/222 Sensitizes Glioma Cells to Temozolomide by Regulating Apoptosis Independently of P53 Status.

miR-214 Modulates the Growth and Migration of Oral Cancer before and after Chemotherapy through Mediating ULK1

[Mir-2110 Affects the Biological Behaviors of Lung Adenocarcinoma by Regulating CDT1].

Downregulation of Mir-375 in Aldosterone-Producing Adenomas Promotes Tumour Cell Growth Via Mtdh

Involvement of Mir-133A and Mir-326 in ADM Resistance of HepG2 Through Modulating Expression of ABCC1

MicroRNA-221-3p is Related to Survival and Promotes Tumour Progression in Pancreatic Cancer: a Comprehensive Study on Functions and Clinicopathological Value

MiRNA-221-3p Desensitizes Pancreatic Cancer Cells to 5-Fluorouracil by Targeting RB1.

Reverse offect of miR-7 on adriamycin resistance of breast cancer cells

The Overexpression of Hypomethylated Mir-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)